Alar Pharmaceuticals Inc. (TPEX:6785)

Alar Pharmaceuticals Statistics

Total Valuation

TPEX:6785 has a market cap or net worth of TWD 18.77 billion. The enterprise value is 16.44 billion.

Market Cap	18.77B
Enterprise Value	16.44B

Important Dates

The last earnings date was Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	Jun 10, 2025

Share Statistics

TPEX:6785 has 66.80 million shares outstanding. The number of shares has increased by 4.69% in one year.

Current Share Class	66.80M
Shares Outstanding	66.80M
Shares Change (YoY)	+4.69%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	24.57%
Owned by Institutions (%)	3.19%
Float	36.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14,980.69
PB Ratio	7.75
P/TBV Ratio	7.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-559.90
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-184.90

Financial Position

The company has a current ratio of 26.49, with a Debt / Equity ratio of 0.00.

Current Ratio	26.49
Quick Ratio	26.06
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	-2,179.23

Financial Efficiency

Return on equity (ROE) is -1.20% and return on invested capital (ROIC) is -3.34%.

Return on Equity (ROE)	-1.20%
Return on Assets (ROA)	-3.24%
Return on Invested Capital (ROIC)	-3.34%
Return on Capital Employed (ROCE)	-5.39%
Revenue Per Employee	46,407
Profits Per Employee	-1.09M
Employee Count	27
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-9.18M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +83.66% in the last 52 weeks. The beta is 0.31, so TPEX:6785's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	+83.66%
50-Day Moving Average	260.82
200-Day Moving Average	182.02
Relative Strength Index (RSI)	63.89
Average Volume (20 Days)	206,986

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6785 had revenue of TWD 1.25 million and -29.36 million in losses. Loss per share was -0.44.

Revenue	1.25M
Gross Profit	903,000
Operating Income	-130.75M
Pretax Income	-38.53M
Net Income	-29.36M
EBITDA	-128.40M
EBIT	-130.75M
Loss Per Share	-0.44

Balance Sheet

The company has 2.34 billion in cash and 4.45 million in debt, giving a net cash position of 2.34 billion or 34.96 per share.

Cash & Cash Equivalents	2.34B
Total Debt	4.45M
Net Cash	2.34B
Net Cash Per Share	34.96
Equity (Book Value)	2.42B
Book Value Per Share	36.24
Working Capital	2.29B

Cash Flow

In the last 12 months, operating cash flow was -58.57 million and capital expenditures -30.33 million, giving a free cash flow of -88.89 million.

Operating Cash Flow	-58.57M
Capital Expenditures	-30.33M
Free Cash Flow	-88.89M
FCF Per Share	-1.33

Margins

Gross Margin	72.07%
Operating Margin	-10,435.28%
Pretax Margin	-3,075.34%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.09%.

Dividend Per Share	0.25
Dividend Yield	0.09%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-4.69%
Shareholder Yield	-4.60%
Earnings Yield	-0.16%
FCF Yield	-0.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6785 has an Altman Z-Score of 66.99.

Altman Z-Score	66.99
Piotroski F-Score	n/a